Literature DB >> 23796241

Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?

Francois Venter, Lucy Allais, Marlise Richter.   

Abstract

The last few years have seen dramatic progress in the development of HIV pre-exposure prophylaxis (PrEP). These developments have been met by ethical concerns. HIV interventions are often thought to be ethically difficult. In a context which includes disagreements over human rights, controversies over testing policies, and questions about sexual morality and individual responsibility, PrEP has been seen as an ethically complex intervention. We argue that this is mistaken, and that in fact, PrEP does not raise new ethical concerns. Some of the questions posed by PrEP are not specific to HIV prophylaxis, but simply standard public health considerations about resource allocation and striking a balance between individual benefit and public good. We consider sexual disinhibition in the context of private prescriptions, and conclude that only unjustified AIDS-exceptionalism or inappropriate moralism about sex supports thinking that PrEP raises new ethical problems. This negative conclusion is significant in a context where supposed ethical concerns about PrEP have been raised, and in the context of HIV exceptionalism.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  HIV; PreP; pre-exposure; prophylaxis

Mesh:

Substances:

Year:  2013        PMID: 23796241     DOI: 10.1111/bioe.12021

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  13 in total

Review 1.  Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.

Authors:  Kellie Freeborn; Carmen J Portillo
Journal:  J Clin Nurs       Date:  2018-09       Impact factor: 3.036

2.  Behavioral Changes Following Uptake of HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in a Clinical Setting.

Authors:  Catherine E Oldenburg; Amy S Nunn; Madeline Montgomery; Alexi Almonte; Leandro Mena; Rupa R Patel; Kenneth H Mayer; Philip A Chan
Journal:  AIDS Behav       Date:  2018-04

3.  Misclassification of sexual health risks in a self-identified low risk cohort of men who have sex with men (MSM) enrolled in a community based PrEP program.

Authors:  Kellie Freeborn; Carmen Portillo; Cherie B Boyer; Glen Milo Santos
Journal:  AIDS Care       Date:  2019-05-25

4.  HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.

Authors:  Susan P Buchbinder; David V Glidden; Albert Y Liu; Vanessa McMahan; Juan V Guanira; Kenneth H Mayer; Pedro Goicochea; Robert M Grant
Journal:  Lancet Infect Dis       Date:  2014-03-07       Impact factor: 25.071

5.  HIV Preexposure Prophylaxis and Condomless Sex: Disentangling Personal Values From Public Health Priorities.

Authors:  Sarah K Calabrese; Kristen Underhill; Kenneth H Mayer
Journal:  Am J Public Health       Date:  2017-08-17       Impact factor: 9.308

Review 6.  The role of healthcare providers in the roll out of preexposure prophylaxis.

Authors:  Douglas S Krakower; Kenneth H Mayer
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

7.  PrEP Implementation Science: State-of-the-Art and Research Agenda.

Authors:  Carlos F Cáceres; Kenneth H Mayer; Rachel Baggaley; Kevin R O'Reilly
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

8.  Pre-exposure prophylaxis in Southern Africa: feasible or not?

Authors:  Willem Daniel François Venter; Frances Cowan; Vivian Black; Kevin Rebe; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

9.  Beyond "getting drugs into bodies": social science perspectives on pre-exposure prophylaxis for HIV.

Authors:  Judith D Auerbach; Trevor A Hoppe
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

10.  The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention.

Authors:  Carlos F Cáceres; Florence Koechlin; Pedro Goicochea; Papa-Salif Sow; Kevin R O'Reilly; Kenneth H Mayer; Peter Godfrey-Faussett
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.